Mon, May 6, 2013
Sun, May 5, 2013
Fri, May 3, 2013
Thu, May 2, 2013
Wed, May 1, 2013
Tue, April 30, 2013
Mon, April 29, 2013
Sun, April 28, 2013
Fri, April 26, 2013
Thu, April 25, 2013
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Sun, April 21, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013
Tue, April 16, 2013
Mon, April 15, 2013
Fri, April 12, 2013
Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
Wed, April 10, 2013

Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference


//health-fitness.news-articles.net/content/2013/ .. e-needham-12th-annual-healthcare-conference.html
Published in Health and Fitness on Wednesday, April 24th 2013 at 10:15 GMT by Market Wire   Print publication without navigation


Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference -- SAN DIEGO, April 24, 2013 /PRNewswire/ --

SAN DIEGO, April 24, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that Kevin Gorman , President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Needham 12th Annual Healthcare Conference in New York City.  

The live presentation takes place on Wednesday, May 1 at 9:20 a.m. Eastern Time / 6:20 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at [ http://www.neurocrine.com ].

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or [ ir@neurocrine.com ].  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for one month.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].

SOURCE Neurocrine Biosciences, Inc.



RELATED LINKS
[ http://www.neurocrine.com ]

Publication Contributing Sources